Sphera Funds Management’s 89bio ETNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-39,675
| Closed | -$583K | – | 112 |
|
|
2025
Q3 | $583K | Sell |
39,675
-166,000
| -81% | -$1.69M | 0.12% | 103 |
|
|
2025
Q2 | $2.02M | Sell |
205,675
-412,668
| -67% | -$3.42M | 0.47% | 68 |
|
|
2025
Q1 | $4.5M | Buy |
618,343
+61,811
| +11% | +$540K | 1.04% | 29 |
|
|
2024
Q4 | $4.35M | Buy |
556,532
+19,985
| +4% | +$165K | 0.79% | 47 |
|
|
2024
Q3 | $3.97M | Buy |
536,547
+10,000
| +2% | +$84.1K | 0.63% | 50 |
|
|
2024
Q2 | $4.22M | Buy |
526,547
+10,665
| +2% | +$95.2K | 0.58% | 55 |
|
|
2024
Q1 | $6M | Buy |
515,882
+107,208
| +26% | +$1.19M | 0.84% | 43 |
|
|
2023
Q4 | $4.56M | Buy |
408,674
+89,373
| +28% | +$821K | 0.73% | 51 |
|
|
2023
Q3 | $4.93M | Buy |
319,301
+184,301
| +137% | +$3.09M | 0.9% | 40 |
|
|
2023
Q2 | $2.56M | Buy |
+135,000
| New | +$2.37M | 0.4% | 65 |
|
|
2023
Q1 | – | Sell |
-180,600
| Closed | -$2.3M | – | 88 |
|
|
2022
Q4 | $2.3M | Sell |
180,600
-478,184
| -73% | -$4.3M | 0.49% | 41 |
|
|
2022
Q3 | $3.81M | Buy |
658,784
+208,784
| +46% | +$917K | 0.53% | 46 |
|
|
2022
Q2 | $1.45M | Buy |
+450,000
| New | +$1.36M | 0.16% | 45 |
|
|
2021
Q1 | – | Sell |
-69,939
| Closed | -$1.7M | – | 181 |
|
|
2020
Q4 | $1.7M | Buy |
69,939
+11,000
| +19% | +$281K | 0.15% | 90 |
|
|
2020
Q3 | $1.51M | Buy |
+58,939
| New | +$1.87M | 0.15% | 82 |
|
Other funds holding ETNB
Sphera Funds Management's ETNB Position: Q4 2025 in Review
Sphera Funds Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 39,675 shares — an estimated $583K sold.
Sphera Funds Management first reported a position in ETNB in Q3 2020 and held it in 15 quarters. The position peaked at $6M in Q1 2024. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.
- Sphera Funds Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
- Sphera Funds Management sold 39,675 89bio shares in Q4 2025, an estimated $583K.
- Sphera Funds Management first reported a position in 89bio in Q3 2020 and held it in 15 quarters.
- Sphera Funds Management's 89bio position peaked at $6M in Q1 2024.
- 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.
Based on Sphera Funds Management's 13F filing for Q4 2025, filed 17 Feb 2026.